Found 2 results
Author Title [ Type(Desc)] Year
Filters: Author is Morgan, Patricia  [Clear All Filters]
Journal Article
M. L. Robb, Rerks-Ngarm, S., Nitayaphan, S., Pitisuttithum, P., Kaewkungwal, J., Kunasol, P., Khamboonruang, C., Thongcharoen, P., Morgan, P., Benenson, M., Paris, R. M., Chiu, J., Adams, E., Francis, D., Gurunathan, S., Tartaglia, J., Gilbert, P., Stablein, D., Michael, N. L., and Kim, J. H., “Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144.”, Lancet Infect Dis, vol. 12, no. 7, pp. 531-7, 2012.
P. Pitisuttithum, Rerks-Ngarm, S., Bussaratid, V., Dhitavat, J., Maekanantawat, W., Pungpak, S., Suntharasamai, P., Vanijanonta, S., Nitayapan, S., Kaewkungwal, J., Benenson, M., Morgan, P., O'Connell, R. J., Berenberg, J., Gurunathan, S., Francis, D. P., Paris, R., Chiu, J., Stablein, D., Michael, N. L., Excler, J. - L., Robb, M. L., and Kim, J. H., “Safety and reactogenicity of canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E vaccination in an efficacy trial in Thailand.”, PLoS One, vol. 6, no. 12, p. e27837, 2011.